Chen Shang-Wen, Shen Wei-Chih, Lin Ying-Chun, Chen Rui-Yun, Hsieh Te-Chun, Yen Kuo-Yang, Kao Chia-Hung
Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.
School of Medicine, China Medical University, Taichung, Taiwan.
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):567-580. doi: 10.1007/s00259-016-3580-5. Epub 2016 Dec 20.
This study investigated the correlation of the matrix heterogeneity of tumors on F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) with gene-expression profiling in patients with pharyngeal cancer and determined the prognostic factors for radiotherapy-based treatment outcomes.
We retrospectively reviewed the records of 57 patients with stage III-IV oropharyngeal or hypopharyngeal cancer who had completed definitive therapy. Four groups of the textural features as well as 31 indices were studied in addition to maximum standard uptake value, metastatic tumor volume, and total lesion glycolysis. Immunohistochemical data from pretreatment biopsy specimens (Glut1, CAIX, VEGF, HIF-1α, EGFR, Ki-67, Bcl-2, CLAUDIN-4, YAP-1, c-Met, and p16) were analyzed. The relationships between the indices and genomic expression were studied, and the robustness of various textural features relative to cause-specific survival and primary relapse-free survival was analyzed.
The overexpression of VEGF was positively associated with the increased values of the matrix heterogeneity obtained using gray-level nonuniformity for zone (GLNUz) and run-length nonuniformity (RLNU). Advanced T stage (p = 0.01, hazard ratio [HR] = 3.38), a VEGF immunoreactive score of >2 (p = 0.03, HR = 2.79), and a higher GLNUz value (p = 0.04, HR = 2.51) were prognostic factors for low cause-specific survival, whereas advanced T stage, a HIF-1α staining percentage of ≥80%, and a higher GLNUz value were prognostic factors for low primary-relapse free survival.
The overexpression of VEGF was associated with the increased matrix index of GLNUz and RLNU. For patients with pharyngeal cancer requiring radiotherapy, the treatment outcome can be stratified according to the textural features, T stage, and biomarkers.
本研究调查了下咽癌患者在F-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描(PET-CT)上肿瘤的基质异质性与基因表达谱之间的相关性,并确定了基于放疗的治疗结果的预后因素。
我们回顾性分析了57例完成确定性治疗的III-IV期口咽癌或下咽癌患者的记录。除了最大标准摄取值、转移瘤体积和总病变糖酵解外,还研究了四组纹理特征以及31个指标。分析了预处理活检标本(Glut1、CAIX、VEGF、HIF-1α、EGFR、Ki-67、Bcl-2、CLaudin-4、YAP-1、c-Met和p16)的免疫组织化学数据。研究了这些指标与基因组表达之间的关系,并分析了各种纹理特征相对于特定病因生存率和无原发复发生存率的稳健性。
VEGF的过表达与使用区域灰度非均匀性(GLNUz)和游程长度非均匀性(RLNU)获得的基质异质性值增加呈正相关。晚期T分期(p = 0.01,风险比[HR] = 3.38)、VEGF免疫反应评分>2(p = 0.03,HR = 2.79)和较高的GLNUz值(p = 0.04,HR = 2.51)是低特定病因生存率的预后因素,而晚期T分期、HIF-1α染色百分比≥80%和较高的GLNUz值是低无原发复发生存率的预后因素。
VEGF的过表达与GLNUz和RLNU的基质指数增加有关。对于需要放疗的下咽癌患者,可根据纹理特征、T分期和生物标志物对治疗结果进行分层。